DE69940805D1 - Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie - Google Patents

Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie

Info

Publication number
DE69940805D1
DE69940805D1 DE69940805T DE69940805T DE69940805D1 DE 69940805 D1 DE69940805 D1 DE 69940805D1 DE 69940805 T DE69940805 T DE 69940805T DE 69940805 T DE69940805 T DE 69940805T DE 69940805 D1 DE69940805 D1 DE 69940805D1
Authority
DE
Germany
Prior art keywords
ige
ige binding
binding
binding sites
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69940805T
Other languages
English (en)
Inventor
Gary A Bannon
Wesley A Burks
Hugh A Sampson
Cocknell Gael
Helm M Ricki
King E Wina
Stanley J Seven
Shin S David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Arkansas
Icahn School of Medicine at Mount Sinai
Original Assignee
University of Arkansas
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Arkansas, Mount Sinai School of Medicine filed Critical University of Arkansas
Application granted granted Critical
Publication of DE69940805D1 publication Critical patent/DE69940805D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
DE69940805T 1998-01-31 1999-01-29 Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie Expired - Fee Related DE69940805D1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US7328398P 1998-01-31 1998-01-31
US7462498P 1998-02-13 1998-02-13
US7463398P 1998-02-13 1998-02-13
US7459098P 1998-02-13 1998-02-13
US14122098A 1998-08-27 1998-08-27
PCT/US1999/002031 WO1999038978A1 (en) 1998-01-31 1999-01-29 Methods and reagents for decreasing allergic reactions

Publications (1)

Publication Number Publication Date
DE69940805D1 true DE69940805D1 (de) 2009-06-10

Family

ID=27535962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940805T Expired - Fee Related DE69940805D1 (de) 1998-01-31 1999-01-29 Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie

Country Status (8)

Country Link
US (1) US7485708B2 (de)
EP (1) EP1051494B1 (de)
JP (1) JP2002501748A (de)
AT (1) ATE430199T1 (de)
AU (1) AU743647B2 (de)
CA (1) CA2319437C (de)
DE (1) DE69940805D1 (de)
WO (1) WO1999038978A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323687C (en) * 1998-03-16 2008-11-25 Alk-Abello A/S Mutant recombinant allergens
ATE390441T1 (de) * 1998-10-30 2008-04-15 Novozymes As Niedrigallergene proteinvarianten
US6686164B1 (en) 1998-10-30 2004-02-03 Novozymes A/S Low allergenic protein variants
US20020009452A1 (en) * 1999-02-10 2002-01-24 Michael Caplan Method for altering undesirable immune responses to polypeptides
AU3717600A (en) * 1999-03-02 2000-09-21 Board Of Trustees Of The University Of Arkansas, The Methods and reagents for decreasing clinical reaction to allergy
WO2000051647A2 (en) * 1999-03-03 2000-09-08 Mount Sinai School Of Medicine Of New York University Animal model of allergies
WO2001036621A2 (en) * 1999-11-19 2001-05-25 Alabama A & M University Down-regulation and silencing of allergen genes in transgenic peanut seeds
US6943010B1 (en) 1999-11-19 2005-09-13 Hortense W. Dodo Down-regulation and silencing of allergen genes in transgenic peanut seeds
WO2001040264A2 (en) * 1999-12-06 2001-06-07 Panacea Pharmaceuticals, Llc. Peptide antigens
CA2394377A1 (en) * 1999-12-09 2001-05-10 Novozymes A/S High throughput screening (hts) assays for protein variants with reducedantibody binding capacity
MXPA02006752A (es) 2000-01-06 2004-09-10 Monsanto Technology Llc Preparacion de proteinas y permutenias desalergenizadas.
GB0006437D0 (en) * 2000-03-17 2000-05-10 Leuven Res & Dev Vzw Compounds for the modulation of allergen sensitivity by antigens sharing T cell epitopes with allergens
US8153414B2 (en) * 2000-04-06 2012-04-10 Allertein Therapeutics, Llc Microbial delivery system
US20020192792A1 (en) * 2000-04-28 2002-12-19 Palle Schneider Laccase mutants
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
US20030175312A1 (en) * 2000-11-16 2003-09-18 Alk-Abello A/S Novel mutant allergens
JP2004521618A (ja) * 2000-11-16 2004-07-22 アルカベロ アクチェセルスカプ 新規変異体アレルゲン
WO2002074250A2 (en) * 2001-03-16 2002-09-26 Panacea Pharmaceuticals Methods and reagents for decreasing clinical reaction to allergy
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
DK1403280T3 (da) 2002-09-27 2005-11-07 Biomay Prod & Handel Hypoallergene allergi-vacciner baseret på timothégræspollenallergenet Phl p 7
US8057800B2 (en) 2004-06-10 2011-11-15 Circassia Limited Immunointeractive molecules and uses thereof
AU2005252268B2 (en) * 2004-06-10 2012-06-28 Aravax Pty Limited Novel immunointeractive molecules and uses thereof
FR2924349B1 (fr) * 2007-12-03 2010-01-01 Dbv Tech Methode de desensibilitation aux allergenes
EP2243791A1 (de) 2009-03-03 2010-10-27 PLS-Design GmbH Klonierung und rekombinante Produktion von Wespengiftprotease und zugehörige Verwendungsverfahren
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
EP2664624A1 (de) 2012-05-15 2013-11-20 Biomay Ag Allergenvarianten
MX2015005636A (es) 2012-10-30 2015-11-16 Univ Monash Moléculas inmunoterapéuticas novedosas y sus usos.
KR102233251B1 (ko) 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
AU2014328483B2 (en) 2013-09-25 2019-11-14 Aravax Pty Ltd Novel immunotherapeutic composition and uses thereof
CN104280555B (zh) * 2014-10-24 2017-09-26 江南大学 一种快速检测花生过敏原Ara h 2的胶体金试纸条及其制备方法
US9920100B2 (en) 2015-06-05 2018-03-20 The Chinese University Of Hong Kong Mimotopes of tropomyosin for use in immunotherapy for shellfish and/or arthropod allergy
CN109295250B (zh) * 2018-10-31 2022-03-22 四川华汉三创生物科技有限公司 一种食源性植物过敏原成分的检测试剂盒和方法
EP3938053A4 (de) * 2019-03-13 2023-03-22 Psomagen, Inc. Auf epitop basierender ansatz für allergiebehandlungen und inhibitoren für morbus crohn

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US548972A (en) * 1895-10-29 Weed-cutter
US576149A (en) * 1897-02-02 Gustavus a
US569345A (en) * 1896-10-13 Albert p
US580862A (en) * 1897-04-20 Cloth computing and measuring machine
SE337223B (de) 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US4171299A (en) 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4338297A (en) 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US4469677A (en) 1980-02-19 1984-09-04 Michael J Gabriel Polypeptide active immunosuppressant fraction
FI76888C (fi) 1981-04-29 1988-12-12 Ciba Geigy Ag Nya medel och foerpackningar foer immunologiska analyser.
US4888170A (en) 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
SE8205908D0 (sv) 1982-10-18 1982-10-18 Pharmacia Diagnostics Ab Sett att bilda polymerskikt
US4849337A (en) 1983-01-31 1989-07-18 Minnesota Mining And Manufacturing Company Assaying allergen specific IgE levels with fluorogenic enzyme labeled antibody
CA1260828A (en) 1983-07-04 1989-09-26 Masakazu Iwai Therapeutic and prophylactic agent for gastrointestinal ulcers
US4579840A (en) 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4816449A (en) 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4696915A (en) 1984-05-25 1987-09-29 Hoffmann-La Roche Inc. Parathymosin alpha
US5026545A (en) 1984-09-17 1991-06-25 Baxter International, Inc. Treatment of allergy and composition therefor
US4658022A (en) 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4900556A (en) 1985-04-26 1990-02-13 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
IL86583A0 (en) 1987-06-04 1988-11-15 Molecular Eng Ass Vaccine containing a derivative of a microbe and method for the production thereof
US5843710A (en) 1987-07-07 1998-12-01 Biotech Australia Pty. Limited And Csiro Vaccines against animal parasitic nematodes
US5049390A (en) 1987-09-02 1991-09-17 Allergy Immuno Technologies, Inc. Liposome containing immunotherapy agents for treating IgE mediated allergies
US5449760A (en) 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5169933A (en) 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
AT393137B (de) 1988-10-14 1991-08-26 Biomay Biotech Prod Verfahren zum screenen einer expressions-cdna- klonbank zur auffindung von polynukleotiden
US5061790A (en) 1989-07-10 1991-10-29 Molecular Diagnostics, Inc. Oxidative denaturation of protein analytes
JP2787162B2 (ja) 1989-08-24 1998-08-13 フマキラー株式会社 精製ダニアレルゲン
CA2073045C (en) 1989-11-03 2007-05-22 Malcolm L. Gefter A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor
US5328991A (en) 1989-11-03 1994-07-12 Immulogic Pharmaceutical Corp. Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes
US5547669A (en) 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
US5652122A (en) 1989-12-21 1997-07-29 Frankel; Alan Nucleic acids encoding and methods of making tat-derived transport polypeptides
WO1991011718A1 (en) 1990-01-31 1991-08-08 Regents Of The Board Of The University Of Oklahoma Assays and treatments for autoimmune diseases
US6897287B1 (en) 1990-01-31 2005-05-24 Oklahoma Medical Research Foundation Ro/SSA peptide reagents for diagnosis of autoantibodies
US5091318A (en) 1990-04-13 1992-02-25 Abbott Laboratories Binding of allergens to a solid phase
US5888762A (en) 1990-06-05 1999-03-30 Centre National De La Recherche Scientifique (Cnrs) Neurotropic growth factors comprising a homeobox peptide
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
EP0495052A1 (de) 1990-08-08 1992-07-22 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Allergene des erlenblütenstaubs und deren anwendungen
WO1992003551A1 (en) 1990-08-13 1992-03-05 Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. Birch pollen allergen p14 for diagnosis and therapy of allergic diseases
AT401180B (de) 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
JP3139777B2 (ja) 1990-08-27 2001-03-05 フマキラー株式会社 組換えダニアレルゲン
WO1992011859A1 (en) 1991-01-08 1992-07-23 Immulogic Pharmaceutical Corporation Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite)
US5219990A (en) 1991-01-28 1993-06-15 Biogen, Inc. Papillomavirus e2 trans-activation repressors
WO1994024281A1 (en) 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
US5350835A (en) 1991-11-05 1994-09-27 Board Of Regents, University Of Texas Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids
JP3156237B2 (ja) 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
WO1993021223A1 (en) 1992-04-13 1993-10-28 Board Of Regents Of The University Of Oklahoma Methods and reagents for diagnosis of autoantibodies
US5719064A (en) 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
AU5411594A (en) 1992-10-27 1994-05-24 Biomay Produktions- Und Handelsgesellschaft M.B.H. Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the (fagales) order
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
CA2086631C (en) 1992-12-22 1998-10-06 J. Gabriel Michael Oral administration of immunologically active biomolecules and other therapeutic proteins
US5558869A (en) 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
ES2260756T3 (es) 1992-12-31 2006-11-01 Heska Corporation Proteina y peptidos alergenicos de caspa de perro y sus usos.
ES2114184T3 (es) 1993-02-12 1998-05-16 Mayo Foundation Composicion a base de microparticulas en fase condensada y procedimiento.
JP3451572B2 (ja) 1993-03-04 2003-09-29 アサヒビール株式会社 改変したダニ主要アレルゲン及びその製造方法
US5710126A (en) 1993-03-12 1998-01-20 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
US6849427B1 (en) 1993-03-12 2005-02-01 Immulogic Pharmaceutical Corp. Nucleic acids encoding a house dust mite allergen, Der p VII, and uses therefor
NZ263913A (en) 1993-03-12 1997-10-24 Immulogic Pharma Corp Lol pi protein allergen from ryegrass and related peptides coding sequences, vectors, protein production and use
AT401937B (de) 1993-04-01 1996-12-27 Biomay Prod & Handel Rekombinantes lieschgras pollen allergen phl p ii
US5830463A (en) 1993-07-07 1998-11-03 University Technology Corporation Yeast-based delivery vehicles
JP3350794B2 (ja) 1993-09-29 2002-11-25 アサヒビール株式会社 改変したダニ主要アレルゲン
JP2828391B2 (ja) 1993-10-29 1998-11-25 東燃株式会社 オリゴ糖を表面に有するリポソーム
US5449669A (en) 1993-11-10 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
US5731157A (en) 1993-12-30 1998-03-24 The Procter And Gamble Company Two-site allergen immunoassay
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
JPH07285875A (ja) 1994-04-19 1995-10-31 Mineo Hayazaki ノミアレルゲンの製造方法および該方法により製造されるノミアレルゲン
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
SE9402089D0 (sv) 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
ES2229263T3 (es) * 1995-03-28 2005-04-16 Asahi Breweries, Ltd. Sustancia alergena para acaridos obtenida mediante ingenieria genetica y proceso para la produccion de la misma.
US5840307A (en) 1995-03-31 1998-11-24 Immulogic Pharmacuetical Corp. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
BE1009359A7 (fr) 1995-05-19 1997-02-04 Univ Bruxelles Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique.
US5820880A (en) 1995-06-07 1998-10-13 The United States Of America As Represented By The Secretary Of The Army Liposomal formulation
US5869040A (en) 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
CN1208438A (zh) 1995-07-28 1999-02-17 玛丽·柯里癌症治疗中心 转运蛋白及其应用
CA2241918C (en) 1995-12-29 2008-12-02 University Of Arkansas Peanut allergens and methods
US5955593A (en) 1996-09-09 1999-09-21 Washington University BH3 interacting domain death agonist
US6017735A (en) 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
BE1011033A6 (fr) 1997-03-05 1999-04-06 Univ Bruxelles Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
DE19713001A1 (de) 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
US5989814A (en) 1997-04-01 1999-11-23 Reagents Of The University Of California Screening methods in eucaryotic cells
US5888760A (en) * 1997-04-10 1999-03-30 Dade Microscan Inc. Universal test systems and methods of use thereof for identifying multiple families of microorganisms
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
EP0877033B1 (de) 1997-05-08 2007-09-12 Amarnath Maitra Verfahren zur Herstellung von hochmonodispersierten Polymeren hydrophiler Nanopartikel
US5891432A (en) 1997-07-29 1999-04-06 The Immune Response Corporation Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
SE9703531D0 (sv) 1997-09-30 1997-09-30 Rudolf Valenta Non-anaphlactic forms of allergens and their use
ATE356630T1 (de) 1998-04-03 2007-04-15 Univ Iowa Res Found Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
DK1219300T3 (da) * 2000-12-28 2007-03-05 Biomay Prod & Handel Behandling af allergi

Also Published As

Publication number Publication date
EP1051494B1 (de) 2009-04-29
AU743647B2 (en) 2002-01-31
US7485708B2 (en) 2009-02-03
US20030049237A1 (en) 2003-03-13
EP1051494A1 (de) 2000-11-15
CA2319437C (en) 2009-06-16
CA2319437A1 (en) 1999-08-05
AU2350599A (en) 1999-08-16
JP2002501748A (ja) 2002-01-22
ATE430199T1 (de) 2009-05-15
WO1999038978A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
DE69940805D1 (de) Verfahren und reagenzien zur verminderung der klinischen reaktion zur allergie
Gutiérrez et al. Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics
WO2000052154A3 (en) Methods and reagents for decreasing clinical reaction to allergy
ATE283473T1 (de) Verfahren zur isolierung von zellen
MXPA02006752A (es) Preparacion de proteinas y permutenias desalergenizadas.
PT699755E (pt) Metodo para obtencao de imunoglobulinas modificadas com imunogenicidade reduzida de dominios variaveis de anticorpos de murideo composicoes que as contem
ATE382053T1 (de) System zur antikörperexpression und- synthese
ATE429448T1 (de) Peptidzusammensetzung als immunogen zur allergiebehandlung.
WO2002042427A3 (en) Mass tags for quantitative analysis
Chamulitrat et al. Nitroxide metabolites from alkylhydroxylamines and N-hydroxyurea derivatives resulting from reductive inhibition of soybean lipoxygenase.
WO1995006728A3 (en) T cell epitopes of ryegrass pollen allergen
WO2002074250A3 (en) Methods and reagents for decreasing clinical reaction to allergy
WO2002061436A8 (en) Methods and devices for quantitation of glycated protein
DE3667061D1 (en) New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
WO1998011232A3 (en) Human nm23-like protein
WO2004000217A3 (en) Vaccines for suppressing ige-mediated allergic disease and methods for using the same
DE60236853D1 (de) Pharmazeutische zusammensetzung aus f(ab) 2- fragmenten von antikörpern und verfahren zu ihrer herstellung
EP0972524A4 (de) Lymphozyten aktivierungsinhibitoren
NO950526D0 (no) T-celleepitoper av raigresspollen-allergen
DE3786673D1 (de) Verfahren zur entfernung unerwuenschter zellen aus menschlichen lymphozytenpopulationen, anwendung des verfahrens zur herstellung monoklonaler antikoerper und dafuer geeigneter kit.
DE60100025D1 (de) Behandlung von Proteinen aus Gelen zur Analyse durch Verwendung von Massenspektrometrie
WO2002059345A3 (en) Nucleic acid encoding ion transporter component protein
DE60233347D1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung
EP1593691A4 (de) Verfahren des erhalts von menschlichen monoklonalen antikörpern zur hemmung der verbreitung von krebszellen
DE69328831D1 (de) Methoden der anwendung von antikörpern gegen humane chorionic gonadotropin verwandte determinanten zur lyse von kranken zellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee